by Admin | Jul 29, 2022 | News & Opinions
Doctors turn to stem cell treatment to heal the youngest hearts Almost one out of 100 babies are born with a heart defect each year in the United States. Many of these babies will need surgery within weeks of birth, followed by more surgeries throughout their lives....
by Admin | Jul 28, 2022 | News & Opinions
Image Caption: New research into factors that control the life and death of hair follicle cells could help people with baldness, as well as wound healing. Credit: Helpaeatcontu/Wikimedia by Jules Bernstein, University of California – Riverside A single chemical...
by Admin | Jul 27, 2022 | News & Opinions
By Fraiser Kansteiner – Fierce Pharma Just a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to tap that expertise. Charles River Laboratories agreed to throw down $875 million...
by admin | Jul 26, 2022 | News & Opinions
By Max Bayer – Fierce Biotech Just a week after Vertex’s stem cell therapy to treat type 1 diabetes was released from an FDA clinical hold, the company is clearing out potential competition by buying ViaCyte for $320 million. The all-cash deal announced Monday...
by Admin | Jul 25, 2022 | News & Opinions, Video
By recreating the helical structure of heart muscles, researchers improve understanding of how the heart beats By Leah Burrows – Harvard John A Paulson School of Engineering and Applied Sciences Heart disease — the leading cause of death in the U.S. — is so...
by Admin | Jul 22, 2022 | News & Opinions
By University of Copenhagen – SciTechDaily.com The University of Copenhagen researchers utilized a mouse model to discover an alternate path that some cells follow to build organs and used that information to exploit a new kind of stem cells as a possible supply...
